HCM
AZN icon

Highlander Capital Management’s AstraZeneca AZN Stock Holding History

Highlander Capital Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$11.3K Hold
42
– – ﹤0.01% 665
2023
Q4 		$11.3K Buy
+42
New +$5.46K ﹤0.01% 684
2021
Q1 		– Sell
-2,900
Closed -$290K – 616
2020
Q4 		$290K Hold
2,900
– – 0.16% 112
2020
Q3 		$318K Buy
+2,900
New +$323K 0.19% 108

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Highlander Capital Management's AZN Position: Q1 2024 in Review

Highlander Capital Management held its AstraZeneca (AZN) position steady in Q1 2024 at 42 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #665.

Highlander Capital Management first reported a position in AZN in Q3 2020 and has held it in 4 quarters since. The position peaked at $318K in Q3 2020. 1,141 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Highlander Capital Management held 42 shares of AstraZeneca worth $11.3K as of Q1 2024.
  • Highlander Capital Management left its AstraZeneca share count unchanged in Q1 2024.
  • AstraZeneca made up ﹤0.01% of Highlander Capital Management's portfolio in Q1 2024, its #665 holding.
  • Highlander Capital Management first reported a position in AstraZeneca in Q3 2020 and has held it in 4 quarters since.
  • Highlander Capital Management's AstraZeneca position peaked at $318K in Q3 2020.
  • 1,141 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Highlander Capital Management's 13F filing for Q1 2024, filed 20 May 2024.